Live Quote · NASDAQGALTHealthcare· Biotechnology

Galectin Therapeutics Inc.

$2.69▼ 4.27%($-0.12)
MKT CAP $177.16MNEXT EARNINGS Mar 30, 2027
50%
Bullish
TickerSpark Score
39/100
▌ Weak
20
Valuation
40
Profitability
60
Growth
44
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GALT research report →

Analyst Price Target
$11.00+308.9% vs. today

Range $11 – $11

Analyst RatingBuy
9 Buy2 Hold0 Sell

Price Chart

-53.14% · this period
$6.51$4.29$2.08Nov 20May 26Nov 20
52-Week Range13% of range
Low
$2.03
Current
$2.69
High
$7.13